| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.27B | +14.1% |
| Cost of Revenue | $1.95B | +17.3% |
| R&D Expense | $74.5M | +1.6% |
| SG&A Expense | $736.0M | +9.1% |
| Operating Income | $586.4M | +10.6% |
| Interest Expense | $75.9M | +51.2% |
| Pre-tax Income | $514.5M | -1.8% |
| Income Tax | $56.2M | +38.1% |
| Net Income | $458.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288.0M | -27.6% |
| Inventory | $479.0M | +25.9% |
| Current Assets | $1.21B | +8.7% |
| Total Assets | $3.99B | +30.8% |
| Current Liabilities | $703.6M | +17.0% |
| Long-term Debt | $2.09B | +45.2% |
| Total Liabilities | $3.05B | +33.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $459.5M | -6.0% |
| Capital Expenditures | $64.0M | +41.0% |
| Investing Cash Flow | -$994.1M | -3045.9% |
| Financing Cash Flow | $437.0M | +182.6% |
| Free Cash Flow | $395.5M | -10.8% |
| -5.2% |
| EPS (Basic) | $5.20 | -3.2% |
| EPS (Diluted) | $5.19 | -2.8% |
| Stockholders' Equity |
| $941.8M |
| +24.1% |